Context Therapeutics Reports First Quarter 2026 Operating and Financial Results

Go back to Context Therapeutics Reports First Quarter 2026 Operating and Financial Results
(NASDAQ: CNTX) Delayed: 0.48 -0.02 (4%)
Previous Close $0.50    52 Week High
Open $0.51    52 Week Low
Day High $0.53    P/E N/A 
Day Low $0.48    EPS
Volume 2,427,166